Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.
YELLOWYELLOW
FEVERFEVER
SUJATA MOHAPATRA.SUJATA MOHAPATRA.
OUTLINEOUTLINE
 IntroductionIntroduction
 Disease BackgroundDisease Background
 DistributionDistribution
 Epidemiology...
Disease BackgroundDisease Background
 First account ofFirst account of
sickness diagnosed assickness diagnosed as
YF occu...
Global DistributionGlobal Distribution
 In 45 countries ofIn 45 countries of
Africa & LatinAfrica & Latin
America.America...
EPIDEMIOLOGYEPIDEMIOLOGY
Flavivirus FibricusFlavivirus Fibricus
ManMan
Forest(>24Forest(>2400
))
YELLOW
FEVER
AgentAgent
 Flavivirus FibricusFlavivirus Fibricus
 Group B ArbovirusGroup B Arbovirus
Reservoir & VectorReservoir & Vector
 MonkeyMonkey
 MosquitoMosquito
Host FactorHost Factor
 All ages & both sexesAll ages & both sexes
 Persons in contact withPersons in contact with
fores...
The SEVIR ModelThe SEVIR Model
Humans can be in one of five categories at a time.
*Virus incubating*Virus incubating
**Con...
Environmental FactorEnvironmental Factor
 ClimateClimate
 Tropical with a relativeTropical with a relative
humidity.humi...
INCUBATION PERIODINCUBATION PERIOD –– 3-6 days3-6 days
PERIOD OF COMMUNICABILITYPERIOD OF COMMUNICABILITY -- Blood ofBlood...
Cycles of YFCycles of YF
TransmissionTransmission
MOSQUITO
MONKE
Y
HUMAN,
MONKE
Y
MOSQUIT
O
HUMAN HUMAN
MOSQUIT
O
MOSQUITO...
Clinical featuresClinical features
Diagnosis &Diagnosis &
ManagementManagement
 Blood studiesBlood studies
 Supportive TreatmentSupportive Treatment
 IV F...
Prevention & ControlPrevention & Control
 17D17D Vaccine,Vaccine,
 SubcutaneouslySubcutaneously 0.5ml0.5ml,,
 Immunity ...
Yellow fever
Yellow fever
Yellow fever
Yellow fever
Yellow fever
Nächste SlideShare
Wird geladen in …5
×

Yellow fever

11.019 Aufrufe

Veröffentlicht am

Yellow fever

Veröffentlicht in: Bildung
  • Als Erste(r) kommentieren

Yellow fever

  1. 1. YELLOWYELLOW FEVERFEVER SUJATA MOHAPATRA.SUJATA MOHAPATRA.
  2. 2. OUTLINEOUTLINE  IntroductionIntroduction  Disease BackgroundDisease Background  DistributionDistribution  EpidemiologyEpidemiology  TransmissionTransmission  Diagnosis & managementDiagnosis & management  Prevention and ControlPrevention and Control  Actions to TakeActions to Take
  3. 3. Disease BackgroundDisease Background  First account ofFirst account of sickness diagnosed assickness diagnosed as YF occurred in 1648.YF occurred in 1648.  Causative agent:Causative agent: genus Flavivirus.genus Flavivirus.  Vector: Aedes aegyptiVector: Aedes aegypti (mosquito).(mosquito).  Nonhuman primatesNonhuman primates maintain disease.maintain disease.
  4. 4. Global DistributionGlobal Distribution  In 45 countries ofIn 45 countries of Africa & LatinAfrica & Latin America.America.  More than 900 millionMore than 900 million people are at risk.people are at risk.  200,000 cases &200,000 cases & 30,000 deaths30,000 deaths worldwide each year.worldwide each year.
  5. 5. EPIDEMIOLOGYEPIDEMIOLOGY Flavivirus FibricusFlavivirus Fibricus ManMan Forest(>24Forest(>2400 )) YELLOW FEVER
  6. 6. AgentAgent  Flavivirus FibricusFlavivirus Fibricus  Group B ArbovirusGroup B Arbovirus
  7. 7. Reservoir & VectorReservoir & Vector  MonkeyMonkey  MosquitoMosquito
  8. 8. Host FactorHost Factor  All ages & both sexesAll ages & both sexes  Persons in contact withPersons in contact with forests.forests.  Wood cutters, Hunters.Wood cutters, Hunters.  Immunity-Immunity- One attack ofOne attack of yellow fever givesyellow fever gives lifelonglifelong immunity.immunity.
  9. 9. The SEVIR ModelThe SEVIR Model Humans can be in one of five categories at a time. *Virus incubating*Virus incubating **Contagious**Contagious ***Includes: survivors, victims, Immune***Includes: survivors, victims, Immune Susceptible Exposed* Infective** Recovered*** Vaccinated
  10. 10. Environmental FactorEnvironmental Factor  ClimateClimate  Tropical with a relativeTropical with a relative humidity.humidity.  Endemic presence ofEndemic presence of disease in the jungle.disease in the jungle.  Social FactorsSocial Factors  Urbanization,Urbanization,  More Populated,More Populated,  Forest.Forest.
  11. 11. INCUBATION PERIODINCUBATION PERIOD –– 3-6 days3-6 days PERIOD OF COMMUNICABILITYPERIOD OF COMMUNICABILITY -- Blood ofBlood of patients is infective during the first 3-4days.patients is infective during the first 3-4days.
  12. 12. Cycles of YFCycles of YF TransmissionTransmission MOSQUITO MONKE Y HUMAN, MONKE Y MOSQUIT O HUMAN HUMAN MOSQUIT O MOSQUITO MOSQUIT O MOSQUITO Jungle Village City www.who.int
  13. 13. Clinical featuresClinical features
  14. 14. Diagnosis &Diagnosis & ManagementManagement  Blood studiesBlood studies  Supportive TreatmentSupportive Treatment  IV FluidsIV Fluids  AntipyreticsAntipyretics  AntibioticsAntibiotics  Use of Mosquito-net orUse of Mosquito-net or mosquito repellents.mosquito repellents.
  15. 15. Prevention & ControlPrevention & Control  17D17D Vaccine,Vaccine,  SubcutaneouslySubcutaneously 0.5ml0.5ml,,  Immunity begins to appear on theImmunity begins to appear on the77thth day & lasts for more thanday & lasts for more than 35 years35 years..  International Certificates.International Certificates.

×